Loading clinical trials...
Loading clinical trials...
An Open-Label, Survey-Based, Multicenter Study to Determine Patient Satisfaction With Single-Use Prefilled Avonex® PEN Autoinjector in Multiple Sclerosis Patients
Conditions
Locations
10
Canada
Foothills Medical Center
Calgary, Alberta, Canada
Saint John Regional Hospital
Saint John, New Brunswick, Canada
MUN Hospital
Saint John's, Newfoundland and Labrador, Newfoundland and Labrador, Canada
Dalhousie MS Research Unit
Halifax, Nova Scotia, Canada
Norfolk Medical Clinic
Guelph, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
Start Date
June 1, 2011
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
September 16, 2013
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions